0001062993-23-018551.txt : 20230927 0001062993-23-018551.hdr.sgml : 20230927 20230927205014 ACCESSION NUMBER: 0001062993-23-018551 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230920 FILED AS OF DATE: 20230927 DATE AS OF CHANGE: 20230927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lapidus Stanley CENTRAL INDEX KEY: 0001678195 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40901 FILM NUMBER: 231285911 MAIL ADDRESS: STREET 1: 101 HARTWELL AVE. CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lucid Diagnostics Inc. CENTRAL INDEX KEY: 0001799011 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 825488042 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 212 949 4319 MAIL ADDRESS: STREET 1: 360 MADISON AVENUE STREET 2: 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 4/A 1 form4a.xml AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4/A 2023-09-20 2023-09-22 0001799011 Lucid Diagnostics Inc. LUCD 0001678195 Lapidus Stanley 360 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10017 1 0 0 0 1 Common stock 2023-09-20 4 S 0 3405 1.45 D 132051 D Common stock 2023-09-20 4 S 0 412 1.44 D 131639 D Common stock 2023-09-21 4 S 0 100 1.44 D 131539 D Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock. Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023. The reported sales of shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. This Form 4 Amendment (this "Amendment") was filed with respect to the initial Form 4 filed September 22, 2023 (the "Initial Form 4") to clarify that the transactions reported on the Initial Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. This is indicated on this Amendment by (i) the checking of the "Rule 10b5-1(c) Transaction Indication" box above Table I and (ii) the addition of Footnote 3. There are no other differences between this Amendment and the Initial Form 4. /s/ Michael A. Gordon, by power of attorney 2023-09-27